Unknown

Dataset Information

0

Genome-Wide Association Study for Incident Myocardial Infarction and Coronary Heart Disease in Prospective Cohort Studies: The CHARGE Consortium.


ABSTRACT: BACKGROUND:Data are limited on genome-wide association studies (GWAS) for incident coronary heart disease (CHD). Moreover, it is not known whether genetic variants identified to date also associate with risk of CHD in a prospective setting. METHODS:We performed a two-stage GWAS analysis of incident myocardial infarction (MI) and CHD in a total of 64,297 individuals (including 3898 MI cases, 5465 CHD cases). SNPs that passed an arbitrary threshold of 5×10-6 in Stage I were taken to Stage II for further discovery. Furthermore, in an analysis of prognosis, we studied whether known SNPs from former GWAS were associated with total mortality in individuals who experienced MI during follow-up. RESULTS:In Stage I 15 loci passed the threshold of 5×10-6; 8 loci for MI and 8 loci for CHD, for which one locus overlapped and none were reported in previous GWAS meta-analyses. We took 60 SNPs representing these 15 loci to Stage II of discovery. Four SNPs near QKI showed nominally significant association with MI (p-value<8.8×10-3) and three exceeded the genome-wide significance threshold when Stage I and Stage II results were combined (top SNP rs6941513: p = 6.2×10-9). Despite excellent power, the 9p21 locus SNP (rs1333049) was only modestly associated with MI (HR = 1.09, p-value = 0.02) and marginally with CHD (HR = 1.06, p-value = 0.08). Among an inception cohort of those who experienced MI during follow-up, the risk allele of rs1333049 was associated with a decreased risk of subsequent mortality (HR = 0.90, p-value = 3.2×10-3). CONCLUSIONS:QKI represents a novel locus that may serve as a predictor of incident CHD in prospective studies. The association of the 9p21 locus both with increased risk of first myocardial infarction and longer survival after MI highlights the importance of study design in investigating genetic determinants of complex disorders.

SUBMITTER: Dehghan A 

PROVIDER: S-EPMC4780701 | biostudies-literature | 2016

REPOSITORIES: biostudies-literature

altmetric image

Publications

Genome-Wide Association Study for Incident Myocardial Infarction and Coronary Heart Disease in Prospective Cohort Studies: The CHARGE Consortium.

Dehghan Abbas A   Bis Joshua C JC   White Charles C CC   Smith Albert Vernon AV   Morrison Alanna C AC   Cupples L Adrienne LA   Trompet Stella S   Chasman Daniel I DI   Lumley Thomas T   Völker Uwe U   Buckley Brendan M BM   Ding Jingzhong J   Jensen Majken K MK   Folsom Aaron R AR   Kritchevsky Stephen B SB   Girman Cynthia J CJ   Ford Ian I   Dörr Marcus M   Salomaa Veikko V   Uitterlinden André G AG   Eiriksdottir Gudny G   Vasan Ramachandran S RS   Franceschini Nora N   Carty Cara L CL   Virtamo Jarmo J   Demissie Serkalem S   Amouyel Philippe P   Arveiler Dominique D   Heckbert Susan R SR   Ferrières Jean J   Ducimetière Pierre P   Smith Nicholas L NL   Wang Ying A YA   Siscovick David S DS   Rice Kenneth M KM   Wiklund Per-Gunnar PG   Taylor Kent D KD   Evans Alun A   Kee Frank F   Rotter Jerome I JI   Karvanen Juha J   Kuulasmaa Kari K   Heiss Gerardo G   Kraft Peter P   Launer Lenore J LJ   Hofman Albert A   Markus Marcello R P MR   Rose Lynda M LM   Silander Kaisa K   Wagner Peter P   Benjamin Emelia J EJ   Lohman Kurt K   Stott David J DJ   Rivadeneira Fernando F   Harris Tamara B TB   Levy Daniel D   Liu Yongmei Y   Rimm Eric B EB   Jukema J Wouter JW   Völzke Henry H   Ridker Paul M PM   Blankenberg Stefan S   Franco Oscar H OH   Gudnason Vilmundur V   Psaty Bruce M BM   Boerwinkle Eric E   O'Donnell Christopher J CJ  

PloS one 20160307 3


<h4>Background</h4>Data are limited on genome-wide association studies (GWAS) for incident coronary heart disease (CHD). Moreover, it is not known whether genetic variants identified to date also associate with risk of CHD in a prospective setting.<h4>Methods</h4>We performed a two-stage GWAS analysis of incident myocardial infarction (MI) and CHD in a total of 64,297 individuals (including 3898 MI cases, 5465 CHD cases). SNPs that passed an arbitrary threshold of 5×10-6 in Stage I were taken to  ...[more]

Similar Datasets

| S-EPMC7665790 | biostudies-literature
| S-EPMC8501606 | biostudies-literature
| S-EPMC2875693 | biostudies-literature
| S-EPMC4753948 | biostudies-literature
| S-EPMC3122147 | biostudies-literature
| S-EPMC3197770 | biostudies-literature
| S-EPMC3025695 | biostudies-literature
| S-EPMC9738248 | biostudies-literature
| S-EPMC8477859 | biostudies-literature
| S-EPMC2923092 | biostudies-literature